Sensitivity and specificity of optical coherence tomography angiography for diagnosis and classification of diabetic retinopathy; a systematic review and meta-analysis

医学 糖尿病性视网膜病变 视网膜病变 糖尿病 眼科 科克伦图书馆 眼底(子宫) 荟萃分析 内科学 内分泌学
作者
Ehsan Namvar,Hamid Ahmadieh,Alireza Maleki,Mohammad Hossein Nowroozzadeh
出处
期刊:European Journal of Ophthalmology [SAGE Publishing]
卷期号:33 (6): 2068-2078 被引量:4
标识
DOI:10.1177/11206721231167458
摘要

Optical coherence tomography angiography (OCTA) is a noninvasive imaging method that can be used for the staging of diabetic retinopathy. In addition, alterations in OCTA parameters can precede the clinical fundus changes. In this review, we aimed to assess the accuracy of OCTA in diagnosis and staging of diabetic retinopathy.Two independent reviewers participated in the literature search using electronic databases (PubMed, Embase, Cochrane Library Central Register of Controlled Trials, ISI, and Scopus) from inception till December 2020. The heterogeneity of data was assessed by Q statistics, Chi-square test and I2 index.Forty-four articles published from 2015 to the end of 2020 were included in this meta-analysis. Of these, 27 were case-control studies, 9 were case series, and 8 were cohort studies. In total, 4284 eyes of 3553 patients were assessed in this study. OCTA could differentiate diabetic retinopathy from diabetes without diabetic retinopathy with a sensitivity of 88% (95% CI: 85% to 92%) and specificity of 88% (95% CI: 85% to 91%). In addition, it could differentiate proliferative diabetic retinopathy from non-proliferative diabetic retinopathy with a sensitivity of 91% (95% CI: 86% to 95%) and specificity of 91% (95% CI:86% to 96%). The sensitivity of OCTA for diagnosing diabetic retinopathy was increased by the size of scan (3 × 3 mm: 85%; 6 × 6 mm: 91%, 12 × 12 mm: 96%).OCTA, as a non-invasive method, has acceptable sensitivity and specificity for diagnosis and classification of diabetic retinopathy. A larger scan size is associated with more sensitivity for discriminating diabetic retinopathy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丘比特应助科研通管家采纳,获得10
刚刚
刚刚
彭于晏应助科研通管家采纳,获得10
刚刚
jinn完成签到,获得积分10
刚刚
乐乐应助科研通管家采纳,获得10
刚刚
刚刚
隐形曼青应助土豪的听筠采纳,获得10
刚刚
天天应助科研通管家采纳,获得10
刚刚
我是老大应助科研通管家采纳,获得10
1秒前
英姑应助小伍同学采纳,获得10
1秒前
Daisy发布了新的文献求助10
1秒前
张有志完成签到 ,获得积分10
1秒前
JamesPei应助科研通管家采纳,获得10
1秒前
丶惑发布了新的文献求助10
1秒前
Mic应助科研通管家采纳,获得10
1秒前
1秒前
Jasper应助科研通管家采纳,获得10
2秒前
柴智浩发布了新的文献求助10
2秒前
2秒前
orixero应助科研通管家采纳,获得10
2秒前
2秒前
lizishu应助科研通管家采纳,获得10
2秒前
WGOIST发布了新的文献求助10
2秒前
bangeyi发布了新的文献求助10
2秒前
CPD应助科研通管家采纳,获得10
2秒前
2秒前
英俊的铭应助科研通管家采纳,获得10
3秒前
3秒前
无极微光应助科研通管家采纳,获得20
3秒前
3秒前
情怀应助科研通管家采纳,获得10
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
Hu完成签到,获得积分10
3秒前
飞飞飞发布了新的文献求助20
3秒前
丘比特应助科研通管家采纳,获得10
3秒前
彭于晏应助科研通管家采纳,获得10
3秒前
打打应助科研通管家采纳,获得10
3秒前
乐乐应助科研通管家采纳,获得10
3秒前
orixero应助科研通管家采纳,获得10
3秒前
天天应助科研通管家采纳,获得10
3秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
What is the Future of Psychotherapy in a Digital Age? 700
The Psychological Quest for Meaning 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5953926
求助须知:如何正确求助?哪些是违规求助? 7160279
关于积分的说明 15932775
捐赠科研通 5088700
什么是DOI,文献DOI怎么找? 2734971
邀请新用户注册赠送积分活动 1695761
关于科研通互助平台的介绍 1617051